Jan 11, 2023 / 11:45PM GMT
Unidentified Analyst -
Hello all, and welcome. My name is [Fazi]. I'm from JPMorgan. It's my pleasure to introduce Karsten Voermann, CFO of GoodRx. And I'll hand it over to him to kick us off.
Karsten Ian Voermann - GoodRx Holdings, Inc. - CFO & Principal Financial Officer
Thank you, Fazi. Very grateful to be here today. And as many of you know, this is GoodRx's first in-person presentation at JPMorgan. We're very excited about that as well, having not been able to participate in person during the COVID period. For that reason, we're going to use this largely as a reintroduction to the company since many folks likely don't know us yet, and many folks certainly haven't seen us here. So again, grateful for the opportunity to participate, Fazi.
Before I get into the details of the story though and that reintroduction, wanted to take a moment to let everyone know that we do have a safe harbor provision, and we may make forward-looking statements. You can find our risk factors in our SEC filings, which may affect our future performance.
Okay. Now with
Goodrx Holdings Inc at JPMorgan Healthcare Conference Transcript
Jan 12, 2023
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers